Our automated scheduling system is available 24/7. Order your test online and receive your donor/registration pass by email. Click Here
Same Day Service
Accredited Drug Testing provides a wide range of substance screening services, with 21 accessible test centers around Livermore, Maine. Our offerings include DOT and non-DOT urine testing, breathalyzer alcohol assessments, EtG alcohol analysis, and hair follicle drug tests for private individuals, companies, and legal requirements. In Livermore, ME, we facilitate both immediate result exams and SAMSA certified lab evaluations. Most test centers are conveniently situated close to your residence or workplace, and same-day services are available. We also provide Occupational Health Testing, Clinical Assessments, and Background Verification services.
Contact us at (800) 221-4291 or register via our website. Select your desired test and a nearby facility—available for personal, employee, or third-party testing. Test scheduling is simple and convenient; reach out to our scheduling team or book online anytime, 24/7. Our efficient, easy-to-use system ensures you can organize drug screening in Livermore without hassle.
* You must register by phone or online to receive your donor pass/registration prior to proceeding to the testing center. You must bring a valid government issued ID along with the registration/barcode number which was sent to you by email.
When you're searching for drug testing near me or drug testing locations, we provide a simple and convenient process to find a drug and alcohol testing location near you that is certified to provide all of your drug and alcohol testing needs.
At our Livermore drug testing collection sites, Accredited Drug Testing provides one of the widest selections of drug and alcohol testing services available. Whether you're an employer, attorney, court, or private individual, we offer both DOT and non-DOT testing options—ranging from rapid tests to comprehensive lab-based screenings—capable of detecting nearly any substance.
DOT Drug Testing and Requirements
DOT Employer Drug Policy Development
If you're an employer needing to test 25 or more employees and looking to save time and money, we offer mobile on-site drug testing where we come to you. Call us today for more information.
In 2022, the drug-related overdose rate in Livermore, Androscoggin County, surged by 12% compared to the previous year.
A 2021 report indicated that 7.5% of high school students in Livermore, Androscoggin County, admitted to recreational drug use.
Androscoggin County ranked fifth in Maine for opioid prescription rates as of 2022, affecting Livermore residents.
In 2023, Livermore police department reported a 15% increase in drug-related arrests in Androscoggin County.
An estimated 9% of Livermore, Androscoggin County adults reported habitual drug use in a 2022 health survey.
The 2022 drug abuse treatment admissions in Androscoggin County, including Livermore, rose by 18% from 2021.
Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.
Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.
A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.
Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.
Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.
Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.
Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.
Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.
The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.
Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.
Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.
Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.
Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears
Employers in Livermore, ME, are recognizing the impact of drug use on workplace productivity and safety. Many businesses adhere to drug testing policies established by the Maine Department of Labor. These policies aim to maintain a drug-free workplace through pre-employment and random drug screenings.
Local companies often collaborate with non-profit organizations and health agencies to educate employees about substance abuse. With the assistance of SAMHSA, employers are encouraged to provide support and resources to employees struggling with addiction, promoting recovery and workforce reintegration.
The government of Livermore, supported by Androscoggin County, has initiated multiple programs to tackle drug abuse. These initiatives include community outreach education and the enhancement of addiction services. In collaboration with Maine DHHS, efforts are being directed to provide resources and support to affected individuals.
Further, state-level cooperation with Maine's Attorney General focuses on legislative measures to control opioid prescriptions and enhance rehabilitation accessibility. Livermore actively participates in state-endorsed programs aimed at reducing drug dependency rates through prevention and treatment services.
Recently, Livermore witnessed a significant drug bust that led to the arrest of multiple individuals involved in a distribution network within Androscoggin County. This operation was a joint effort between local police and federal agencies, emphasizing the community's vigilance against drug activities.
Community forums and events are regularly held to raise awareness about the dangers of drug abuse. These gatherings, often sponsored by local organizations, aim to educate residents and prevent drug-related activities in the future.
Accredited Drug Testing offers fast, reliable employment screening services in Livermore, ME. Trusted by employers nationwide for accurate results and exceptional service.
Maine Department of Health and Human Services
Maine Health Access Foundation
Northern Light Health
Cary Medical Center
Maine General
Spring Harbor Hospital
MaineHealth
Maine Attorney General
Quickly find trusted local drug testing centers in Livermore, ME — fast, convenient, and reliable every time!
Quickly find a local DOT drug testing center in Livermore, ME — fast, reliable, convenient nationwide service!
DNA testing for legal and non-legal purposes including child support, and child custody around Livermore, ME.
Including specimen collector training, DER training, reasonable suspicion training and much more in Livermore, ME.v
Get fast, accurate hair drug testing at our convenient Livermore, ME locations—results you can trust, every time!
Fast, reliable alcohol testing to keep your workplace safe and compliant every single day in Livermore, ME.
Reliable nationwide drug testing services ensuring accuracy, compliance, and quick results for businesses and individuals in Livermore, ME.
Accurate 5 panel drug testing with fast, confidential results—trusted by Livermore, ME employers and individuals nationwide.
Comprehensive 10 panel drug testing with fast, reliable results—trusted for Livermore, ME workplace and personal testing needs.
Convenient on-site mobile drug testing with fast, reliable results—saving time while keeping your Livermore, ME workplace compliant.
Certified DOT physicals with quick, reliable exams to keep Livermore, ME drivers compliant and on the road with confidence.
Join our DOT consortium for hassle-free compliance, random testing management, and reliable driver safety solutions.
Time was running out before my Cdl got downgraded because of a violation I had on clearinghouse. I couldn't find an employer to send me for my return to duty test, but these guys had my test scheduled and done in the same day! They saved my cdl. Thank you again!
Michael Williams - 12/2/2024
I always have a good experience setting up company driver drug screens through ADT. I'm really happy I found them while searching online, they have made my job much easier.
Exodus Heath - 2/13/2025
I use their service for new hire and DOT employee's. Spoke with Taisha Walker this morning, and she was very helpful. She made the process smooth and seamless.
Christina Galdos - 3/9/2025